Patients of lymphoma patients in China are released heavy!

On September 13, 2022, the "China Guidelines for the Lympoloma of the China Anti -Cancer Association" jointly organized by the China Anti -Cancer Association Popularization Professional Committee, the lymphoma Professional Committee, and the Hematoma Tumor Professional Committee. The Guide to the Chinese Anti -Cancer Association lymphoma patient (hereinafter referred to as the "Patient Guide") gathers the wisdom of the top lymphoma experts in the country, combined with the latest progress of domestic and foreign lymphoma diagnosis and treatment, and carefully created the guidelines of the first lymphoma patient in China. Authoritative and practical.

Professor Shi Yuankai, former chairman of the lymphoma professional committee of the Chinese Academy of Medical Sciences, the former chairman of the lymphoma Professional Committee of the China Anti -Cancer Association, Professor Qiu Lugui, Honorary Chairman of the Honorary Council of the Hemorrhea Professional Committee of the Chinese Academy of Medical Sciences, Professor Qiu Lugui, Honorary Council of the China Anti -Cancer Association, Cancer Hospital of Harbin Medical University, China Professor Zhang Qingyuan, chairman of the lymphoma Professional Committee of the Anti -Cancer Association, Professor Ji Chunyan, Chairman of the Blood Tumor Professional Committee of Shandong University, Professor Ji Chunyan, Chairman of the China Anti -Cancer Association, Professor Tian Yantao Dozens of authoritative experts in the field of the field witnessed the release of the "Patient Guide".

In the opening speech, Professor Shi Yuankai said that the "Patient Guide" brought together the latest knowledge and the latest concepts of disease management of lymphoma diagnosis and treatment. Build a tumor prevention and control system and promote the implementation of a healthy Chinese solution.

Professor Qiu Lugui mentioned that the incidence of lymphoma ranks first among hematological tumors. After the release of "Patient Guide", it can avoid the damage of the good and bad information, which helps increase the cure rate and long -term survival rate of lymphoma.

Professor Zhang Qingyuan said in his speech that the guide not only benefited patients, but also a good helper for lymphoma professional medical staff. It is expected that the majority of patients can better understand lymphoma and correctly accept standardized treatment.

Professor Ji Chunyan believes that the release of the "Patient Guide" is an important means to conscientiously implement the "Healthy China 2030" planning outline and achieve a new model of popular science education in science education in accurate and normal tumors.

Professor Tian Yantao said that he hoped that the experts, young doctors in the lymphoma industry and the Popular Science Professional Committee cooperated to interpret the "Patient Guide", and used the guidelines to perform secondary creations, transmitting popular science knowledge to the case of every lymphoma patient. On the heart.

After the wonderful speech of the chairman of the conference, all the guests at the meeting raised their hands to witness and witness the official release of the "Guide to the Chinese Anti -Cancer Association lymphoma patient".

After the release ceremony, many participating experts conducted in -depth interpretation of the core knowledge of the Patient Guide. The founder of lymphoma House and the relevant field experts explore the cognitive needs and popular science plan of lymphoma patients through online connection. Many experts share online experience in lymphoma science popularization, showing the public's wonderfulness. Knowledge feast.

Many experts in the discussion session said that the "Patient Guide" is rich in content, which is not only beneficial to the patient's understanding of lymphoma, but also helps medical staff to improve the level of diagnosis and treatment and science thinking, making the communication between doctors and patients more smooth and more effective, and ultimately benefit patients. Different from the fragmented knowledge of other ways, the "Patient Guide" has the characteristics of comprehensive, systematic, and standardized, and is authoritative. The release of the guidelines of lymphoma patients will better promote the standardization of lymphoma diagnosis and treatment.

The conference of this guideline triggered a heated discussion of experts, and many experts said that the release of the "Patient Guide" could closer the connection between doctors, nurses, and patients. It is expected that the whole society can care more about lymphoma patients, and also pay more attention to the treatment and prevention of lymphoma, and regular medical examination screening. The science popularization of lymphoma is far away. With the opportunity of the guideline, it is expected that all parties will work together to promote the popular science propaganda of lymphoma.

- END -